After Glaxo's genital herpes vaccine flop, check out Agenus Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : After Glaxo's genital herpes vaccine flop, check out Agenus

GSK 46.86

-0.2%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: albertaft who wrote (16)	1/24/2015 1:26:56 PM
From: robert b furman	Read Replies (1) of 22

Hi albertaft, Sounds excellent from all perspectives. Any idea what a vaccine can draw for a selling price? A very high price would be cheaper than the very expensive costs to make one who has it recover to health. Wonderful to have your insight here and someone to discuss with.LOL Bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next